Johnson & Johnson's two-dose Ebola vaccine regimen is safe, well tolerated and produces a strong immune response in people over the age of one, according to two new papers published in The Lancet Infectious Diseases.
Sep 14, 2021
0
10
Giving young children the world's first malaria vaccine RTS,S/AS01E and antimalarial drugs before the rainy season could substantially reduce cases of life-threatening malaria in the African Sahel, suggests a new study published ...
Aug 26, 2021
0
166
The most powerful tool for combating COVID is not a drug or a vaccine, but a method. A randomized trial is the best way to discover what works and what doesn't. This method underlies much of the progress in modern medicine, ...
Aug 23, 2021
0
5
Most common bone and joint (orthopaedic) procedures, such hip replacements and shoulder repair surgery, are not backed up by high quality evidence, mainly because of a lack of definitive trials, suggests an analysis of data ...
Jul 7, 2021
0
6
Two doses of CoronaVac are safe and provoke a strong antibody response among children and adolescents aged 3-17 years, according to a randomised controlled trial of 550 young people published in The Lancet Infectious Diseases ...
Jun 29, 2021
0
9
A smartphone-based eye screening and referral system used in the community has been shown to almost triple the number of people with eye problems attending primary care, as well as increasing appropriate uptake of hospital ...
Jun 21, 2021
0
7
Patients with chronic kidney dysfunction frequently develop thickening of the heart muscle, so-called left ventricular hypertrophy. This is particularly pronounced in patients who are in the late stage of renal dysfunction, ...
Apr 22, 2021
0
6
Using breast screening clinics to introduce lifestyle advice has the potential to improve women's health, a study from the universities of Aberdeen and Dundee has found.
Mar 11, 2021
0
2
A new trial in NSW has resulted in an up to 24 percent reduction in the number of prescriptions issued for opioids to patients with acute back pain in emergency departments.
Mar 10, 2021
0
7
Exercise intensity appears to make no difference to risk of mortality among older adults, suggests a randomised controlled trial from Norway published by The BMJ today.
Oct 7, 2020
0
9
